Home › Multiple Sclerosis › Michigan
Multiple Sclerosis clinical trials in Michigan
10 studies for Multiple Sclerosis are looking for participants at sites in Michigan.
Cities in Michigan
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Ann Arbor
- TG Therapeutics Investigational Trial Site, Detroit
- TG Therapeutics Investigational Trial Site, Farmington
- and 2 more
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT06433752Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Michigan Institute for Neurological Disorders- Site Number : 8400004, Farmington Hills
RecruitingPhase 3
Ages 18 to 60 · All sexes · Updated Sep 15, 2026 · NCT07325292RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of Michigan, Ann Arbor
- Henry Ford Health, Novi
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 15, 2026 · NCT07002034A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
- Northwest Neurology, Southfield
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Sep 9, 2026 · NCT06782490A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- TG Therapeutics Investigational Trial Site, Ann Arbor
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06680037Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research
- Kahana Oculoplastic and Orbital Surgery, Livonia
RecruitingPhase 3
Ages 18 to 50 · All sexes · Updated Aug 14, 2026 · NCT07623668A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Michigan Institute of Neurological, Farmington Hills
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Jul 29, 2026 · NCT07225504Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype
- University of Michigan, Ann Arbor
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Jul 17, 2026 · NCT05269628A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
- Quest Research Institute, Farmington Hills
RecruitingPhase 2
Ages 18 to 55 · All sexes · Updated Jun 15, 2026 · NCT06735248Investigating the Effect of Ocrelizumab in African Americans and Caucasians With Relapsing Multiple Sclerosis
- Wayne State University, Detroit
RecruitingObservational study
Ages 18 to 60 · All sexes · Updated Jun 6, 2022 · NCT04458688From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.